Annette Adams to Bone Density Conservation Agents
This is a "connection" page, showing publications Annette Adams has written about Bone Density Conservation Agents.
Connection Strength
4.010
-
Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates. Reply. N Engl J Med. 2020 11 26; 383(22):2189-2190.
Score: 0.719
-
Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates. N Engl J Med. 2020 08 20; 383(8):743-753.
Score: 0.705
-
Fracture Risk During and After Bisphosphonate Drug Holidays: A Matter of Methods? Med Care. 2020 05; 58(5):417-418.
Score: 0.691
-
Determinants of Oral Bisphosphonate Use Beyond 5 Years. J Manag Care Spec Pharm. 2020 Feb; 26(2):197-202.
Score: 0.679
-
Trends in bisphosphonate initiation within an integrated healthcare delivery system. Am J Manag Care. 2017 Dec 01; 23(12):e421-e422.
Score: 0.584
-
Skeletal effects of combined medical and surgical management of primary hyperparathyroidism. Surgery. 2020 01; 167(1):144-148.
Score: 0.166
-
Using Pharmacy Data and Adherence to Define Long-Term Bisphosphonate Exposure in Women. J Manag Care Spec Pharm. 2019 Jun; 25(6):719-723.
Score: 0.162
-
Predicting Adherence and Persistence with Oral Bisphosphonate Therapy in an Integrated Health Care Delivery System. J Manag Care Spec Pharm. 2017 Apr; 23(4):503-512.
Score: 0.139
-
Sensitivity and specificity of radiographic characteristics in atypical femoral fractures. Osteoporos Int. 2017 01; 28(1):413-417.
Score: 0.135
-
The effect of osteoporosis management on proximal humeral fracture. J Shoulder Elbow Surg. 2015 Feb; 24(2):191-8.
Score: 0.029